Analysts fell to the sidelines weighing in on Myriad Genetics (MYGN – Research Report), Pfizer (PFE – Research Report) and RegenXBio (RGNX – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Myriad Genetics (MYGN)
In a report issued on August 12, Puneet Souda from SVB Securities maintained a Hold rating on Myriad Genetics. The company’s shares closed last Monday at $27.88.
According to TipRanks.com, Souda is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Myriad Genetics is a Hold with an average price target of $32.00, a 17.1% upside from current levels. In a report issued on August 5, Cowen & Co. also maintained a Hold rating on the stock with a $32.00 price target.
See today’s best-performing stocks on TipRanks >>
Pfizer (PFE)
In a report issued on August 12, David Risinger from SVB Securities maintained a Hold rating on Pfizer, with a price target of $105.00. The company’s shares closed last Monday at $49.75.
According to TipRanks.com, Risinger is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pfizer with a $61.75 average price target, implying a 23.6% upside from current levels. In a report issued on July 29, Goldman Sachs also maintained a Hold rating on the stock with a $50.00 price target.
RegenXBio (RGNX)
SVB Securities analyst Mani Foroohar maintained a Hold rating on RegenXBio on August 12. The company’s shares closed last Monday at $33.50.
According to TipRanks.com, Foroohar has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for RegenXBio with a $46.60 average price target, representing a 40.2% upside. In a report issued on August 4, RBC Capital also maintained a Hold rating on the stock with a $47.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MYGN:
